A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before

NCT04760626 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1085

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin icodec
DRUG: Insulin Glargine 100U/mL
DRUG: Insulin Degludec
DRUG: Insulin Glargine 300U/mL

Sponsor

Novo Nordisk A/S